221 related articles for article (PubMed ID: 21732610)
1. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.
Chang M; Yang CS; Huang DM
ACS Nano; 2011 Aug; 5(8):6156-63. PubMed ID: 21732610
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
Shieh YA; Yang SJ; Wei MF; Shieh MJ
ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
[TBL] [Abstract][Full Text] [Related]
3. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
4. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
He X; Hai L; Su J; Wang K; Wu X
Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
[TBL] [Abstract][Full Text] [Related]
5. A polyvalent aptamer system for targeted drug delivery.
Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
[TBL] [Abstract][Full Text] [Related]
7. RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.
Pi F; Zhang H; Li H; Thiviyanathan V; Gorenstein DG; Sood AK; Guo P
Nanomedicine; 2017 Apr; 13(3):1183-1193. PubMed ID: 27890659
[TBL] [Abstract][Full Text] [Related]
8. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-conjugated DNA nano-ring as the carrier of drug molecules.
Srivithya V; Roun H; Sekhar Babu M; Jae Hyung P; Sung Ha P
Nanotechnology; 2018 Mar; 29(9):095602. PubMed ID: 29271356
[TBL] [Abstract][Full Text] [Related]
10. DNA-capped nanoparticles designed for doxorubicin drug delivery.
Alexander CM; Maye MM; Dabrowiak JC
Chem Commun (Camb); 2011 Mar; 47(12):3418-20. PubMed ID: 21286626
[TBL] [Abstract][Full Text] [Related]
11. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
12. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
Zhou J; Rossi JJ; Shum KT
Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
[TBL] [Abstract][Full Text] [Related]
13. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
14. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
Hu QD; Fan H; Ping Y; Liang WQ; Tang GP; Li J
Chem Commun (Camb); 2011 May; 47(19):5572-4. PubMed ID: 21468443
[TBL] [Abstract][Full Text] [Related]
15. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
[TBL] [Abstract][Full Text] [Related]
16. Aptamers embedded in polyacrylamide nanoparticles: a tool for in vivo metabolite sensing.
Nielsen LJ; Olsen LF; Ozalp VC
ACS Nano; 2010 Aug; 4(8):4361-70. PubMed ID: 20731422
[TBL] [Abstract][Full Text] [Related]
17. Review: doxorubicin delivery systems based on chitosan for cancer therapy.
Tan ML; Choong PF; Dass CR
J Pharm Pharmacol; 2009 Feb; 61(2):131-42. PubMed ID: 19178759
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
Cuong NV; Hsieh MF; Chen YT; Liau I
J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
20. Kinetic capillary electrophoresis-based affinity screening of aptamer clones.
Yunusov D; So M; Shayan S; Okhonin V; Musheev MU; Berezovski MV; Krylov SN
Anal Chim Acta; 2009 Jan; 631(1):102-7. PubMed ID: 19046686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]